Our Leadership
Our aim is to advance the care of critically ill patients
From our technicians to our CEO, here you’ll find individuals whose actions speak louder than words. People who strive to make a difference in the lives of critically ill patients and the clinicians who care for them.
Daniel Tassé – Chairman and Chief Executive Officer
“When people become critically ill, their entire world changes — they are fully reliant on healthcare professionals, drugs, and technology. They have no choice. That’s where we can make a real difference. By providing advanced therapies and support to the professionals who treat them in the most crucial moments of their lives, we can give them the solutions that no one else is offering.”
Matthew M. Bennett – Senior Vice President Legal and Corporate Development
“How many people can say they actually look forward to going to work in the morning? I feel fortunate to be part of this group. Working with a team of highly passionate people who strive to advance science beyond where it has ever been before is something that I am excited to be a part of.”
James Briggs – Senior Vice President Human Resources
“When people ask me what we do at Ikaria my answer is simple: People who work at Ikaria are here to do more than just a job. Our employees are a special group…from our scientists to our distribution associates.”
Douglas Greene, MD – Executive Vice President Research and Development
“Only by listening to clinicians, understanding their needs, and observing their challenges firsthand can we fully respond to the complexities of critical care. Our development of therapies is constantly refined by our presence in, commitment to, and passion for this complex arena. Together, we will advance critical care to the next level.”
Stephen Ross – Senior Vice President Commercial Operations
“Having a clear, well-articulated corporate vision is important, but the true value of a company lies in its ability to make a difference in the lives of patients. To stand side-by-side with a respiratory therapist in a NICU and see a baby who was previously struggling to get enough oxygen turn a healthy pink color—that makes me so very proud of what we do.”
Lien-Lung (L.L.) Sheu, PhD, has served as our Senior Vice President of Global Manufacturing and Operations since December 2010
“Maximizing the full scientific potential of a drug is obviously very important. With a reliable supply chain, the full therapeutic potential of Ikaria’s products can be brought to critically ill patients—when time is of the essence. So we ask many practical questions like: ‘What can be done to more effectively deliver Ikaria drugs and delivery systems to patients in today’s hospital environment?”
